Literature DB >> 12362211

Lower gastrointestinal bleeding and ischemic colitis.

Jamie R Newman1, Mary Anne Cooper.   

Abstract

OBJECTIVE: To compare the incidence and clinical characteristics of lower gastrointestinal (LGI) bleeding due to ischemic colitis with those with LGI bleeding of other causes.
METHODS: A chart review was performed of patients admitted with LGI bleeding to Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, between July 1, 1997 and January 31, 2000.
RESULTS: Of 124 patients with LGI bleeding, 24 cases were due to ischemic colitis, 62 to diverticulosis, 11 to inflammatory bowel disease (IBD) and 27 to all other causes ('others'). The average ages of patients in each group were 66.5, 76.5, 40.5 and 77.5 years, respectively. Patients with ischemic colitis were statistically younger than those with diverticular bleeding and 'others'. Patients with IBD were younger than those in the other three groups. The only statistical difference for vascular disease risks was hypertension, because of its absence from the IBD group. Three patients with ischemic colitis underwent blood transfusions, while 23 with diverticulosis, 15 'others' and none with IBD received blood. Three patients with ischemic colitis and one patient from the 'others' group died. More women (75) than men (49) had LGI bleeding - in total and within each subgroup. Of women with LGI bleeding, many more with ischemic colitis (44.4%) than with diverticulosis (3.0%), IBD (0%) or 'others' (5.6%) were taking estrogen.
CONCLUSIONS: Ischemic colitis was the second most common cause of LGI bleeding. LGI bleeding from all causes was more common in women than in men. Many more women in the ischemic colitis group than in the other groups were using estrogen therapy.

Entities:  

Mesh:

Year:  2002        PMID: 12362211     DOI: 10.1155/2002/374682

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  8 in total

Review 1.  [New epidemiology of acute gastrointestinal hemorrhage].

Authors:  H-R Koelz; M Arn
Journal:  Chirurg       Date:  2006-02       Impact factor: 0.955

2.  ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI).

Authors:  Lawrence J Brandt; Paul Feuerstadt; George F Longstreth; Scott J Boley
Journal:  Am J Gastroenterol       Date:  2014-12-23       Impact factor: 10.864

Review 3.  Ischaemic colitis: practical challenges and evidence-based recommendations for management.

Authors:  Alex Hung; Tom Calderbank; Mark A Samaan; Andrew A Plumb; George Webster
Journal:  Frontline Gastroenterol       Date:  2019-12-13

4.  Strictures, diaphragms, erosions or ulcerations of ischemic type in the colon should always prompt consideration of nonsteroidal anti-inflammatory drug-induced lesions.

Authors:  Manfred Stolte; Diana Karimi; Michael Vieth; Hildegard Volkholz; Klaus Dirschmid; Sigrid Rappel; Birgit Bethke
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

5.  Endoscopic findings and clinicopathologic characteristics of ischemic colitis: a report of 85 cases.

Authors:  Xiaoping Zou; Jun Cao; Yulin Yao; Wenjia Liu; Longdian Chen
Journal:  Dig Dis Sci       Date:  2008-12-17       Impact factor: 3.199

6.  What is the predictor of surgical mortality in adult colorectal perforation? The clinical characteristics and results of a multivariate logistic regression analysis.

Authors:  Chao-Wen Hsu; Jui-Ho Wang; Ya-Hsin Kung; Min-Chi Chang
Journal:  Surg Today       Date:  2016-09-20       Impact factor: 2.549

7.  Amphetamine-related ischemic colitis causing gastrointestinal bleeding.

Authors:  Ragesh Panikkath; Deepa Panikkath
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-07

8.  Prediction of severity and outcomes of colon ischaemia using a novel prognostic model: a clinical multicenter study.

Authors:  Xinbo Ai; Yuping Chen; Jiajian Qian; Bin Zhou; Zhenjiang Wang; Yanjun Zhang; Aimin Li; Feiyue Gong; Wensheng Pan; Bo Shen; Side Liu
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.